GenRx Voriconazole voriconazole 200mg tablet blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

voriconazole, Quantity: 200 mg

제공처:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Voriconazole

약제 형태:

Tablet

구성:

Excipient Ingredients: magnesium stearate; polyvinyl alcohol; croscarmellose sodium; macrogol 8000; purified talc; titanium dioxide; lactose monohydrate

관리 경로:

Oral

패키지 단위:

56

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Voriconazole is indicated for treatment of the following fungal infections: ? Invasive aspergillosis. ? Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). ? Serious fungal infections caused by Scedosporium spp and Fusarium spp. ? Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

제품 요약:

Visual Identification: White coloured, modified oval-shaped, biconvex film-coated tablets, engraved with "APO" on one side and "VOR 200" on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2016-01-27